Objectives This study aimed to determine whether certain lifestyle factors, specifically alcohol consumption, smoking, physical activity, sleep duration and sleep quality, are associated with an ...
Investing.com -- Gossamer Bio (NASDAQ:GOSS) shares fell 80% Monday after the company’s seralutinib failed to meet the primary endpoint in its Phase 3 PROSERA trial for pulmonary arterial hypertension.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results